NCT00372255 - Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

November 17, 2005

Primary Completion Date

March 28, 2006

Study Completion Date

March 28, 2006

Conditions

Influenza

Interventions

BIOLOGICAL

Influsplit SSW® 2005/2006

Study influenza vaccine was administered intramuscularly in the non-dominant arm

Trial Locations (18)

10315

GSK Investigational Site, Berlin

10999

GSK Investigational Site, Berlin

13055

GSK Investigational Site, Berlin

18106

GSK Investigational Site, Rostock

18109

GSK Investigational Site, Rostock

18246

GSK Investigational Site, Bützow

24937

GSK Investigational Site, Flensburg

25813

GSK Investigational Site, Husum

25821

GSK Investigational Site, Bredstedt

25899

GSK Investigational Site, Niebüll

97070

GSK Investigational Site, Würzburg

01877

GSK Investigational Site, Bischofswerda

01067

GSK Investigational Site, Dresden

01159

GSK Investigational Site, Dresden

01169

GSK Investigational Site, Dresden

04178

GSK Investigational Site, Leipzig

04317

GSK Investigational Site, Leipzig

04808

GSK Investigational Site, Wurzen